Get the Stockscreener App
0.7032
1.71%
-0.0122
After Hours:
.70
-0.0032
-0.46%
Tevogen Bio Holdings Inc stock is traded at $0.7032, with a volume of 286.58K.
It is down -1.71% in the last 24 hours and down -18.77% over the past month.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
See More
Previous Close:
$0.7154
Open:
$0.71
24h Volume:
286.58K
Relative Volume:
0.34
Market Cap:
$138.32M
Revenue:
-
Net Income/Loss:
$52.50M
P/E Ratio:
24.16
EPS:
0.0291
Net Cash Flow:
$-4.13M
1W Performance:
-5.22%
1M Performance:
-18.77%
6M Performance:
-33.03%
1Y Performance:
-35.49%
1-Day Range:
$0.675
$0.7105
1-Week Range:
$0.675
$0.7427
52-Week Range:
$0.6403
$3.09
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Name
Tevogen Bio Holdings Inc
Sector
Industry
Phone
646-807-8832
Address
15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN
Compare TVGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TVGN
Tevogen Bio Holdings Inc
|
0.7032 | 140.72M | 0 | 52.50M | -4.13M | 0.0291 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Initiated | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc Stock (TVGN) Latest News
Can momentum traders help lift Tevogen Bio Holdings Inc. Equity WarrantMarket Growth Review & Safe Swing Trade Setups - newser.com
Is Tevogen Bio Holdings Inc. stock a top pick in earnings seasonMarket Sentiment Review & Weekly Return Optimization Plans - newser.com
Is Tevogen Bio Holdings Inc. Equity Warrant stock near bottom after declineTrade Performance Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Can a trend reversal in Tevogen Bio Holdings Inc. Equity Warrant lead to recoveryQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - newser.com
Published on: 2025-10-14 03:18:45 - newser.com
Why Tevogen Bio Holdings Inc. stock remains a top recommendationInsider Buying & AI Enhanced Trading Signals - newser.com
Tevogen Bio Holdings Inc. Equity Warrant stock chart pattern explainedSwing Trade & Reliable Intraday Trade Alerts - newser.com
Real time scanner hits for Tevogen Bio Holdings Inc. Equity Warrant explainedMarket Performance Recap & Verified Technical Trade Signals - newser.com
Why Tevogen Bio Holdings Inc. (G28) stock could break out in 2025Trade Analysis Report & Growth Oriented Trade Recommendations - newser.com
What’s next for Tevogen Bio Holdings Inc. stock priceJuly 2025 Fed Impact & Advanced Technical Signal Analysis - newser.com
Is it time to cut losses on Tevogen Bio Holdings Inc.Weekly Risk Report & AI Forecast for Swing Trade Picks - newser.com
Tevogen Bio Holdings Inc. stock outlook for YEAR2025 Big Picture & Free AI Powered Buy and Sell Recommendations - newser.com
Applying Elliott Wave Theory to Tevogen Bio Holdings Inc. Equity WarrantWeekly Risk Summary & Smart Allocation Stock Reports - newser.com
Analyzing recovery setups for Tevogen Bio Holdings Inc. investorsTrade Signal Summary & Free Fast Entry Momentum Trade Alerts - newser.com
Reversal indicators forming on Tevogen Bio Holdings Inc. stockWeekly Loss Report & Free Real-Time Market Sentiment Alerts - newser.com
What drives Tevogen Bio Holdings Inc G28 stock priceStochastic Oscillator Alerts & Free Daily Market Summary and Trend Reports - earlytimes.in
Will Tevogen Bio Holdings Inc. Equity Warrant outperform the marketJuly 2025 PostEarnings & Community Consensus Trade Alerts - newser.com
Published on: 2025-10-10 09:21:27 - newser.com
Price action breakdown for Tevogen Bio Holdings Inc.Market Activity Report & Entry Point Confirmation Signals - newser.com
Tevogen Bio Holdings Inc. Equity Warrant recovery potential after sell offJuly 2025 Summary & Free Daily Entry Point Trade Alerts - newser.com
Tevogen Bio Holdings Inc. Equity Warrant stock momentum explained2025 Price Targets & Free Real-Time Volume Trigger Notifications - newser.com
Technical signs of recovery in Tevogen Bio Holdings Inc. Equity WarrantJuly 2025 Action & Risk Controlled Stock Alerts - newser.com
Candlestick signals on Tevogen Bio Holdings Inc. stock todayJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
Tevogen Bio's (TVGN) "Sell (E+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Detecting price anomalies in Tevogen Bio Holdings Inc. Equity Warrant with AITrade Risk Summary & High Accuracy Trade Alerts - newser.com
Using Ichimoku Cloud for Tevogen Bio Holdings Inc. Equity Warrant technicalsIndex Update & Advanced Swing Trade Entry Plans - newser.com
Is it too late to sell Tevogen Bio Holdings Inc. Equity WarrantEarnings Miss & High Conviction Investment Ideas - newser.com
What makes Tevogen Bio Holdings Inc. stock attractive to growth funds2025 Key Highlights & Risk Controlled Stock Alerts - newser.com
Can trapped investors hope for a rebound in Tevogen Bio Holdings Inc.Portfolio Performance Report & Weekly Breakout Stock Alerts - newser.com
Will Tevogen Bio Holdings Inc. stock see PE expansionInsider Selling & AI Enhanced Trading Alerts - newser.com
Is Tevogen Bio Holdings Inc. (G28) stock attractive post correctionJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Is Tevogen Bio Holdings Inc Equity Warrant a good long term investmentAnalyst Downgrades & Big Profit Low Investment - earlytimes.in
Applying chart zones and confluence areas to Tevogen Bio Holdings Inc. Equity WarrantQuarterly Performance Summary & Risk Adjusted Swing Trade Ideas - newser.com
What data driven models say about Tevogen Bio Holdings Inc.’s futureStock Surge & Free Safe Entry Trade Signal Reports - newser.com
Tevogen Bio Holdings Inc Stock (TVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):